Live Poll Results — Which heavily marketed arthritis drug was voluntarily withdrawn from the market
See real-time poll results. Powered by AIPolls.Net.
Pharmaceutical Product Launch Failures
The pharmaceutical industry has seen numerous high-profile product launches that ultimately failed despite significant investment in research, development, and marketing. These failures often occur due to unexpected side effects, regulatory issues, or market competition. Test your knowledge about one of the most notorious medical product launch failures in recent history!
Which heavily marketed arthritis drug was voluntarily withdrawn from the market in 2004 after being linked to increased risk of heart attacks and strokes?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Vioxx (rofecoxib) by Merck', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Bextra (valdecoxib) by Pfizer', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Celebrex (celecoxib) by Pharmacia', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Humira (adalimumab) by Abbott', 'is_correct': False} | 0 | 0% |